Search - tctmd.com

Displaying 1 - 20 of 277

Sort: Relevancy | Date

News Daily News

Revascularization Decisions in the Elderly Require a Holistic Approach: AHA

Caitlin E. Cox

November 24, 2025

News Daily News

ACC: It’s Time for Clinicians to Address Inflammation in CVD

Caitlin E. Cox

October 03, 2025

News Conference News ESC 2025

AQUATIC: More Than 6 Months After PCI, Don’t Use Aspirin With OAC

Todd Neale

September 01, 2025

News Conference News ESC 2025

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

Michael O'Riordan

August 30, 2025

News Daily News

For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis

Yael L. Maxwell

August 14, 2025

News Daily News

Trade-offs With Invasive Strategy in Older Patients With ACS: Meta-analysis

Michael O'Riordan

July 03, 2025

News Daily News

JACC Dedicates Issue to Deep Dive on Latest ACS Guidelines

Todd Neale

June 06, 2025

News Conference News EuroPCR 2025

‘Quick and Sustained’ Bumps in HR and BP When Beta-blockers Stopped Post-MI

Michael O'Riordan

May 29, 2025

News Daily News

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Michael O'Riordan

March 26, 2025

News Daily News

ACC Releases ‘Concise Clinical Guidance’ for Cardiogenic Shock Care

Caitlin E. Cox

March 19, 2025

News Daily News

Early Invasive Treatment May Help Highest-Risk Women With NSTE ACS

Yael L. Maxwell

March 10, 2025

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

News Daily News

Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More

Michael O'Riordan

December 06, 2024

News Conference News AHA 2024

ZODIAC: Decision-Support Tool Doesn’t Sway Lipid-Lowering Treatments in ACS

Michael O'Riordan

November 21, 2024

Presentation AHA 2024

OptimiZation Of Lipid Lowering Therapies Using A Decision Support System In Patients With Acute Coronary Syndrome (ZODIAC): A Randomized Controlled Trial

Presenter: Kausik K. Ray

November 17, 2024

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

News Daily News

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

Michael O'Riordan

September 20, 2024

News Conference News ESC 2024

More Support for Ticagrelor Monotherapy After PCI, Especially in ACS

Yael L. Maxwell

September 10, 2024

News Conference News ESC 2024

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

Michael O'Riordan

September 01, 2024

News Daily News

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Michael O'Riordan

August 26, 2024

Advertisement

Revascularization Decisions in the Elderly Require a Holistic Approach: AHA

ACC: It’s Time for Clinicians to Address Inflammation in CVD

AQUATIC: More Than 6 Months After PCI, Don’t Use Aspirin With OAC

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis

Trade-offs With Invasive Strategy in Older Patients With ACS: Meta-analysis

JACC Dedicates Issue to Deep Dive on Latest ACS Guidelines

‘Quick and Sustained’ Bumps in HR and BP When Beta-blockers Stopped Post-MI

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

ACC Releases ‘Concise Clinical Guidance’ for Cardiogenic Shock Care

Early Invasive Treatment May Help Highest-Risk Women With NSTE ACS

Top Coronary Artery Disease News in 2024

Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More

ZODIAC: Decision-Support Tool Doesn’t Sway Lipid-Lowering Treatments in ACS

OptimiZation Of Lipid Lowering Therapies Using A Decision Support System In Patients With Acute Coronary Syndrome (ZODIAC): A Randomized Controlled Trial

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

More Support for Ticagrelor Monotherapy After PCI, Especially in ACS

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content